Page last updated: 2024-08-24

3-iodobenzylguanidine and Cholera Infantum

3-iodobenzylguanidine has been researched along with Cholera Infantum in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cole, M; Ellershaw, C; Lewis, IJ; Pearson, AD; Pinkerton, CR; Tweddle, DA1
Aburano, T; Bunko, H; Hisada, K1

Reviews

1 review(s) available for 3-iodobenzylguanidine and Cholera Infantum

ArticleYear
[New horizons for in vivo nuclear medicine in 1980s].
    Rinsho hoshasen. Clinical radiography, 1985, Volume: 30, Issue:5

    Topics: 3-Iodobenzylguanidine; Amphetamines; Biliary Tract Diseases; Brain Diseases; Coronary Disease; Gastrointestinal Diseases; Humans; Imino Acids; Iodobenzenes; Iofetamine; Krypton; Liver Diseases; Lung Diseases; Neoplasms; Radionuclide Imaging; Technetium; Technetium Tc 99m Lidofenin; Thallium; Tomography, Emission-Computed

1985

Trials

1 trial(s) available for 3-iodobenzylguanidine and Cholera Infantum

ArticleYear
OPEC/OJEC for stage 4 neuroblastoma in children over 1 year of age.
    Medical and pediatric oncology, 2001, Volume: 36, Issue:1

    Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Diseases; Bone Neoplasms; Carboplatin; Child, Preschool; Cisplatin; Cyclophosphamide; Diphosphonates; Disease-Free Survival; Etoposide; Female; Gastrointestinal Diseases; Humans; Incidence; Infant; Iodine Radioisotopes; Kidney Diseases; Male; Neoplasm Staging; Nervous System Diseases; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Remission Induction; Survival Analysis; Survival Rate; Technetium Compounds; Treatment Outcome; Vincristine

2001